Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001170621 | SCV001333211 | uncertain significance | Cardiomyopathy | 2018-02-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001170621 | SCV001345112 | uncertain significance | Cardiomyopathy | 2024-08-19 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with arginine at codon 82 of the TNNI3 protein. Computational prediction tools indicate that this variant has a deleterious impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with hypertrophic cardiomyopathy and in one healthy control individual (PMID: 22876777). This variant has been identified in 1/241594 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |